← FDA Drug Approvals (Drugs@FDA)

ROCKLATAN

NDA · New Drug Application · Sponsor: ALCON LABS INC · Approved 2019-03-12

Drug application

FDA Application #
NDA208259
Application type
New Drug Application
Brand name
ROCKLATAN
Generic name
NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%
Active ingredients
LATANOPROST; NETARSUDIL DIMESYLATE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Prescription
Sponsor
ALCON LABS INC
Manufacturer
Alcon Laboratories, Inc.
First approval
2019-03-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown